TWC
BCYC

TD Waterhouse Canada’s Bicycle Therapeutics BCYC Stock Holding History

TD Waterhouse Canada’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$699 – 2073
2025
Q2 		$699 Hold
100
– – ﹤0.01% 1833
2025
Q1 		$785 Hold
100
– – ﹤0.01% 1766
2024
Q4 		$1.4K Buy
+100
New +$2.14K ﹤0.01% 1752

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

TD Waterhouse Canada's BCYC Position: Q3 2025 in Review

TD Waterhouse Canada sold out of Bicycle Therapeutics (BCYC) in Q3 2025, closing a stake of 100 shares — an estimated $699 sold.

TD Waterhouse Canada first reported a position in BCYC in Q4 2024 and held it in 3 quarters. The position peaked at $1.4K in Q4 2024. 99 funds tracked by Wall St. Rank hold BCYC as of Q3 2025.

  • TD Waterhouse Canada reported no remaining Bicycle Therapeutics position as of Q3 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 100 Bicycle Therapeutics shares in Q3 2025, an estimated $699.
  • TD Waterhouse Canada first reported a position in Bicycle Therapeutics in Q4 2024 and held it in 3 quarters.
  • TD Waterhouse Canada's Bicycle Therapeutics position peaked at $1.4K in Q4 2024.
  • 99 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2025.

Based on TD Waterhouse Canada's 13F filing for Q3 2025, filed 3 Nov 2025.